Abstract
Febrile seizures (FSs) typically occur at the onset of fever and do not recur within the same febrile episode despite enduring or increased hyperthermia. Recurrent seizures during the same febrile episode are considered “complex,” with potentially altered prognosis. A characterized immature rat model of FS was used to test the hypotheses that (1) a first FS influences the threshold temperature for subsequent ones, and (2) the underlying mechanisms involve the release and actions of the endogenous inhibitory hippocampal neuropeptide Y (NPY). Experimental FSs were induced two or three times, at 3- to 4-h intervals, and threshold temperatures measured. To determine the potential effects of seizure-induced endogenous NPY on thresholds for subsequent seizures, an antagonist of the major hippocampal NPY receptor (type 2) was infused prior to induction of the second seizure. As an indicator of NPY release, NPY expression was determined 4 and 24 h later. Threshold core and brain temperatures for hyperthermic seizures were consistent with those observed during human fever. Threshold temperatures for a second and third seizure were significantly and progressively higher than those required for the first. This “protective” effect involved induction of endogenous NPY because it was abolished by the NPY antagonist. In addition, NPY mRNA expression was increased in dentate gyrus, CA3 and CA1, after an experimental FS, consistent with peptide release. Collectively these data indicate that the absence of repetitive seizures during a febrile episode involves the inhibitory actions of endogenous NPY, suggesting that the signaling cascade triggered by this peptide might provide targets for therapeutic intervention.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aldenhoff J. B., Gruol D. L., Rivier J., Vale W., and Siggins G. R. (1983) Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221, 875–877.
American Academy of Pediatrics: Committee on Quality Improvement, Subcommittee on Febrile Seizures. (1999) Practice parameter: long-term treatment of the child with simple febrile seizures. Pediatrics 103, 1307–1309.
Annegers J. F., Hauser W. A., Shirts S. B., and Kurland L. T. (1987) Factors prognostic of unprovoked seizures after febrile convulsions. N. Engl. J. Med. 316, 493–498.
Baram T. Z. (2002) Animal models for febrile seizures, in Febrile Seizures, Baram, T. Z., and Shinnar, S., eds., Academic Press, San Diego, CA, pp. 189–203.
Baram T. Z. and Hatalski C. G. (1998) Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci. 21, 471–476.
Baram T. Z., Hirsch E., Snead O. C. III, and Schultz L. (1992) Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann. Neurol. 31, 488–494.
Bender R. A., Dubé C., Gonzalez-Vega R., Mina E. W., and Baram T. Z. (2003) Mossy fiber plasticity and enhanced hippocampal excitability, without hippocampal cell loss or altered neurogenesis, in an animal model of prolonged febrile seizures. Hippocampus 13, 399–412.
Berg A. T. (2002) Recurrent febrile seizures, in Febrile Seizures, Baram, T. Z., and Shinnar, S., eds., Academic Press, San Diego, CA, pp. 37–52.
Berg A. and Shinnar S. (1996a) Unprovoked seizures in children with febrile seizures: short-term outcome. Neurology 47, 562–568.
Berg A. T. and Shinnar S. (1996b) Complex febrile seizures. Epilepsia 37, 126–133.
Berg A. T., Shinnar S., Hauser W. A., Alemany M., Shapiro E. D., Salomon M. E., and Crain E. F. (1992) A prospective study of recurrent febrile seizures. N. Engl. J. Med. 327, 1122–1127.
Brunson K. L., Eghbal-Ahmadi M., Bender R., Chen Y., and Baram T. Z. (2001) Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc. Natl. Acad. Sci. U. S. A. 98, 8856–8861.
Chen Y., Bender R., Frotscher M., and Baram T. Z. (2001) Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J. Neurosci. 21, 7171–7181.
Colbourne F., Nurse S. M., and Corbett D. (1993) Spontaneous postischemic hyperthermia is not required for severe CA1 ischemic damage in gerbils. Brain Res. 623, 1–5.
Deller T. and Leranth C. (1990) Synaptic connections of neuropeptide Y (NPY) immunoreactive neurons in the hilar area of the rat hippocampus. J. Comp. Neurol. 300, 433–447.
Dubé C., Chen K., Eghbal-Ahmadi M., Brunson K., Soltesz I., and Baram T. Z. (2000) Prolonged febrile seizures in immature rat model enhance hippocampal excitability long-term. Ann. Neurol. 47, 336–344.
Eghbal-Ahmadi M., Avishai-Eliner S., Hatalski C. G., and Baram T. Z. (1999) Differential regulation of the expression of corticotropin-releasing factor receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input and food intake. J. Neurosci. 19, 3982–3991.
El Bahh B., Cao J. Q., Beck-Sickinger A. G., and Colmers W. F. (2002) Blockade of neuropeptide Y(2) receptors and suppression of NPY’s anti-epileptic actions in the rat hippocampal slice by BIIE0246. Br. J. Pharmacol. 136, 502–509.
Gruber B., Greber S., Rupp E., and Sperk G. (1994) Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus 4, 474–482.
Hatalski C. G., Brunson K.L., Tantayanubutr B., Chen Y., and Baram T. Z. (2000) Neuronal activity and stress differentially regulate hippocampal and hypothalamic corticotropin-releasing hormone expression in the immature rat. Neuroscience 101, 571–580.
Henker R. A., Brown S. D., and Marion D. W. (1998) Comparison of brain temperature with bladder and rectal temperatures in adults with severe head injury. Neurosurgery 42, 1071–1075.
Hokfelt T., Broberger C., Xu Z. Q., Sergeyev V., Ubink R., and Diez M. (2000) Neuropeptides—an overview. Neuropharmacology 39, 1337–1356.
Hollrigel G. S., Chen K., Baram T. Z., and Soltesz I. (1998) The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 84, 71–79.
International League Against Epilepsy: Commission on Classification and Terminology. (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 33, 661–666.
Klapstein G. J. and Colmers W. F. (1993) On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3, 103–111.
Kohler C., Eriksson L., Davies S., and Chan-Palay V. (1986) Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J. Comp. Neurol. 244, 384–400.
Malmstrom R. E. (2001) Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide YY(2) receptor antagonist, in vivo. Br. J. Pharmacol. 133, 1073–1080.
Merali Z., McIntosh J., Kent P., Michaud D., and Anisman H. (1998) Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J. Neurosci. 18, 4758–4766.
Nelson K. B. and Ellenberg J. H. (1981) Febrile seizures, Raven Press, New York.
Offringa M., Bossuyt P. M., Lubsen J., Ellenberg J. H., Nelson K. B., Knudsen F. U., et al. (1994) Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J. Pediatr. 124, 574–584.
Richichi C., Lin E. J., Stefanin D., Colella D., Ravizza T., Grignaschi G., et al. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci. 24, 3051–3059.
Schwab S., Spranger M., Aschof A., Steiner T., and Hacke W. (1997) Brain temperature monitoring and modulation in patients with severe MCA infarction. Neurology 48, 762–767.
Schwarzer C., Kofler N., and Sperk G. (1998) Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol. Pharmacol. 53, 6–13.
Sherwood N. M. and Timiras P.S. (1970) A Stereotaxic Atlas of the Developing Rat Brain, University of California Press Berkeley, CA.
Stafstrom C. E. (2002) The incidence and prevalence of febrile seizures, in Febrile Seizures, Baram, T.Z., and Shinnar, S., eds., Academic Press, San Diego, CA, pp. 1–21.
Toth Z., Yan X. X., Haftoglou S., Ribak C. E., and Baram T. Z. (1998) Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J. Neurosci. 18, 4285–4294.
Verity C. M. and Golding J. (1991) Risk of epilepsy after febrile convulsions: a national cohort study. Br. Med. J. 303, 1373–1376.
Vezzani A. and Sperk G. (2004) Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides 38, 245–252.
Vezzani A., Schwarzer C., Lothman E. W., Williamson J., and Sperk G. (1996) Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res. 26, 267–279.
Woldbye D. P., Larsen P. J., Mikkelsen J. D., Klemp K., Madsen T. M., and Boldwig T. G. (1997) Inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat. Med. 3, 761–764.
Woldbye D. P., Madsen T. M., Larsen P. J., Mikkelsen J. D., and Bolwig T. G. (1996) Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 737, 162–168.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dubé, C., Brunson, K.L., Eghbal-Ahmadi, M. et al. Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold. J Mol Neurosci 25, 275–284 (2005). https://doi.org/10.1385/JMN:25:3:275
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:25:3:275